Delivery Order SPE2DB22D1017-SPE2DB25FF8NT

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $3,417.69 Firm Fixed Price contract has a completion date of May 11, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,862,399 units of the pharmaceutical product Chlorthalidone 25 mg tablets. The contract is a Firm Fixed Price Delivery Order valued at $2,568.59, with a period of performance through September 19, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will be providing these essential medication supplies to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,674.50 contract is for the delivery of Chlorthalidone 25 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Chlorthalidone 25 mg tablets. The $18,967.65 firm-fixed-price delivery order was placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.06 Firm Fixed Price Delivery Order contract is for the supply of CHLORTHALIDONE 25 MG TABLET 100S medical tablets, with a period of performance through May 30, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB21FQ2Z0, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,571.27 Firm Fixed Price delivery order is for the supply of 4,554,799,368 units of the pharmaceutical product Chlorthalidone 25 mg Tablet. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award is for the supply of Chlorthalidone 25 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,323.61, and has an ultimate completion date of June 16, 2023. The contract does not...
This federal contract award, with an ID of SPE2DB25D7056|SPE2DB25FTMCP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,539.77 delivery order contract is for the supply of 4,567,572,950 units of the medication Chlorthalidone 50 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2025. This award is part of a larger Indefinite Delivery...
This federal contract award is for the delivery of 4,564,465,708 chlorthalidone 25 mg tablets (1,000s) to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 1, 2024, with a completion date of May 2, 2024. The contract type is a Delivery Order with a Firm Fixed Price of $2,791.12. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.34 firm fixed-price delivery order is for the supply of 1,000 units of the pharmaceutical Chlorthalidone 25 mg tablets, with a performance period through July 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF8NT
    Delivery Order

This federal contract award, with ID SPE2DB22D1017|SPE2DB25FF8NT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,292.66 firm fixed-price delivery order is for the supply of 4,567,692,282 units of the medication Chlorthalidone 25 mg tablets.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no mention of any major subcontractors. The DLA, a defense agency, is the funding agency for this award, which aligns with its mission of providing supplies and services to the U.S. military and other federal agencies.

Generated 6/24/25, 9:43 AM